These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Deregulated chromatin remodeling in the pathobiology of brain tumors. Spyropoulou A, Piperi C, Adamopoulos C, Papavassiliou AG. Neuromolecular Med; 2013 Mar; 15(1):1-24. PubMed ID: 23114751 [Abstract] [Full Text] [Related]
3. Epigenetic regulation of gene expression as an anticancer drug target. Ferguson LR, Tatham AL, Lin Z, Denny WA. Curr Cancer Drug Targets; 2011 Feb; 11(2):199-212. PubMed ID: 21158714 [Abstract] [Full Text] [Related]
8. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets. Herranz M, Esteller M. Methods Mol Biol; 2007 Feb; 361():25-62. PubMed ID: 17172706 [Abstract] [Full Text] [Related]
12. Epigenetic drugs against cancer: an evolving landscape. Di Costanzo A, Del Gaudio N, Migliaccio A, Altucci L. Arch Toxicol; 2014 Sep; 88(9):1651-68. PubMed ID: 25085708 [Abstract] [Full Text] [Related]
13. Melanoma epigenetics: novel mechanisms, markers, and medicines. Lee JJ, Murphy GF, Lian CG. Lab Invest; 2014 Aug; 94(8):822-38. PubMed ID: 24978641 [Abstract] [Full Text] [Related]